Skip to search.
 FTSE 100 Down 0.10%

Gilead Sciences Inc. (GILD)

-NasdaqGS
85.60 Down 1.57(1.80%) 4 May 21:00
Prev Close:87.17
Open:86.66
Bid:85.95 x 100
Ask:86.25 x 200
1y Target Est:111.29
Beta:1.25902
Earnings Date:26 Jul - 1 Aug (Est.)
Day's Range:85.41 - 86.99
52wk Range:81.89 - 123.37
Volume:12,187,907
Avg Vol (3m):11,834,700
Market Cap:115.39b
P/E (ttm):7.19
EPS (ttm):11.91
Div & Yield:1.88 (2.16%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 1.80%115.39b
GSKDown 1.83%102.49b
PFEDown 0.89%206.81b

Key Statistics

Forward P/E (1 yr):6.90
P/S (ttm):3.65
Ex-Dividend Date:14-Jun-16

Analysts

Annual EPS Est (Dec-16) :12.11
Quarterly EPS Est (Jun-16) :3.00
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):5.66

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback